Prepare for the end of the epic bubble in US stocks
US stocks are as expensive as they’ve ever been. How can you prepare your portfolio for a bubble bursting?


Last week, Tesla’s founder Elon Musk sent a two-word message on social-media site Twitter: “Use Signal”. It referred to an encrypted messaging service. But by the start of this week, a tiny unrelated medical devices firm – Signal Advance – had seen its value surge by more than 5,100%, reports Bloomberg. Mistaken identity is not unheard of in markets, but a 50-fold gain in three days for an unknown stock suggests that right now investors are far more afraid of missing out than they are of any downside.
No wonder Jeremy Grantham, a respected market historian and co-founder of US asset manager GMO, is now convinced we’re in “a fully fledged epic bubble”. Tesla itself – the pin-up stock for this bubble – has seen its share price surge more than tenfold since its low point in March last year. It became the world’s most valuable car maker in July. It makes the rise in bitcoin (see page 4), another speculative asset, seem tame by comparison.
Examples abound. Eoin Treacy notes on fullertreacymoney.com that the number of big companies trading on a price/sales ratio of more than ten (meaning that the firm would have to pay out 100% of revenues for ten years running to pay investors back in a decade) is at levels last seen during the dotcom bubble. Comparing the market capitalisation of the S&P 500 with US GDP has been dismissed as outdated – about 40% of S&P earnings come from outside the US. But as John Authers notes on Bloomberg, according to Jason DeSena Trennert of Strategas Research Partners, the S&P 500 is now as costly as it was in 2000, even if you compare it to global GDP. Initial public offerings (IPOs) are surging despite the pandemic and a particularly speculative type of financial vehicle – the SPAC – listed in record numbers last year. Complacency abounds.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
So what can you do? Selling up and sheltering in cash is not the best option. “Calling the week, month or quarter of the top is all but impossible,” notes Grantham. But note that the US is very much the epicentre of this bubble. Asset manager Vanguard last month noted that US stocks have beaten international markets (as measured by MSCI indices) by a huge eight percentage points a year on average, over the past decade. The majority of that outperformance has been due to two things. First, investors have been increasingly willing to pay a premium for US stocks over their global peers, which has left US stocks looking expensive. Second, the dollar has gained against most other currencies. That is unlikely to be repeated in the coming decade – with the US starting from higher valuations, international stocks are more likely to win out this time. No one has a crystal ball. But if you are heavily invested in the US, now looks a good time to take some profit and invest in cheaper markets.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
John Stepek is a senior reporter at Bloomberg News and a former editor of MoneyWeek magazine. He graduated from Strathclyde University with a degree in psychology in 1996 and has always been fascinated by the gap between the way the market works in theory and the way it works in practice, and by how our deep-rooted instincts work against our best interests as investors.
He started out in journalism by writing articles about the specific business challenges facing family firms. In 2003, he took a job on the finance desk of Teletext, where he spent two years covering the markets and breaking financial news.
His work has been published in Families in Business, Shares magazine, Spear's Magazine, The Sunday Times, and The Spectator among others. He has also appeared as an expert commentator on BBC Radio 4's Today programme, BBC Radio Scotland, Newsnight, Daily Politics and Bloomberg. His first book, on contrarian investing, The Sceptical Investor, was released in March 2019. You can follow John on Twitter at @john_stepek.
-
Barclays begins paying up to £100 compensation to customers after banking outage
Barclays will pay up to £7.5 million in compensation to customers after its banking services were disrupted by an IT outage
By Daniel Hilton Published
-
Review: Shangri-La Paris – an ode to the world’s best food
Natasha Langan enjoys fine French and Chinese cuisine at the Shangri-La Paris
By Natasha Langan Published
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge Published
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge Published
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field Published
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs Published
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward Published
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves Published
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine Published
-
Pensions revolution: how to profit from the trends shaping the UK pension system
The UK pension system is one of the biggest in the world. Big changes are under way, says Rupert Hargreaves
By Rupert Hargreaves Published